Deferasirox Suppliers & Bulk Manufacturers
Available Forms: Tablets for Oral Suspension
Available Strengths: 125 mg, 250 mg, 500 mg
Reference Brands: Exjade, Jadenu (film-coated)
Category:
Anemia
Deferasirox treats transfusion-related iron overload. Available as Exjade and Jadenu in multiple strengths. Suitable for global pharma B2B supply.
Deferasirox is available in Tablets for Oral Suspension
and strengths such as 125 mg, 250 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Deferasirox is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Deferasirox can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Deferasirox is a leading oral iron chelation therapy used to manage chronic iron overload in patients receiving long-term blood transfusions, such as those with thalassemia or sickle cell disease. It is available as 125 mg, 250 mg, and 500 mg tablets for oral suspension, and 90 mg, 180 mg, and 360 mg film-coated tablets (Jadenu®). Trusted brands like Exjade and Jadenu are approved in the US and EU. Deferasirox is manufactured in GMP-certified facilities and is ideal for pharma B2B distribution, including hospitals, clinics, and global buyers. Contact us for bulk export and regulatory support.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing